Skip to main content
Market intelligence
BCRXHealthcare

Biocryst Pharmaceuticals Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
May 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 18, 2026Amy E McKeeCorporate insiderSale11,180$8.97$100,285
May 13, 2026Alane P BarnesChief Legal OfficerSale62,500$9.54$596,250